- US12594264utility2026Modulators of Alpha-synuclein Proteolysis and Associated Methods of Use0 cites
- US12577255utility2026Mdm2-based Modulators of Proteolysis and Associated Methods of Use0 cites
- US12569464utility2026Protein-protein Interaction Inducing Technology0 cites
- US12559486utility2026Tau-protein Targeting Compounds and Associated Methods of Use0 cites
- US12559506utility2026Indazole Based Compounds and Associated Methods of Use0 cites
- US12552783utility2026Modulators of Proteolysis and Associated Methods of Use0 cites
- US12496301utility2025Use of Androgen Receptor Degrader for the Treatment of Spinal and Bulbar Muscular Atrophy0 cites
- US12473294utility2025Selective Modulators of Mutant LRRK2 Proteolysis and Associated Methods of Use0 cites
- US12448399utility2025Cereblon-based KRAS Degrading Protacs and Uses Related Thereto0 cites
- US12441708utility2025Cereblon Ligands and Bifunctional Compounds Comprising the Same0 cites
- US12427144utility2025Compounds and Methods for the Targeted Degradation of Androgen Receptor0 cites
- US12419960utility2025Compounds and Methods for the Targeted Degradation of Androgen Receptor and Associated Methods of Use0 cites
- US12310975utility2025Modulators of BCL6 Proteolysis and Associated Methods of Use0 cites
- US12312316utility2025Compounds and Methods for the Targeted Degradation of Androgen Receptor0 cites
- US12286419utility2025Methods of Manufacturing a Bifunctional Compound0 cites
- US12275716utility2025Modulators of Estrogen Receptor Proteolysis and Associated Methods of Use0 cites
- US12239711utility2025Cereblon Ligands and Bifunctional Compounds Comprising the Same0 cites
- US12208095utility2025Methods of Treating Breast Cancer with Tetrahydronaphthalene Derivatives as Estrogen Receptor Degraders0 cites
- US12180193utility2024Accelerating Fibrosarcoma Protein Degrading Compounds and Associated Methods of Use0 cites
Page 1 of 2Next →